U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888973) titled 'Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases' on Jan. 14.
Brief Summary: The goal of this study is to learn if mesenchymal stem cell therapy (treatment group) can effectively treat autoimmune diseases, when compared to normal saline (given to placebo group). The primary outcome measures will be clinical improvement based on the respective disease specific clinical scores, normalization of T-lymphocyte subsets and > 50% reduction in disease specific antibody titres. The study will also document the type and frequency of any adverse event or side effects, reported by or seen in any of the trial participants.
...